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Abstract
In parallel with the obesity epidemic in the world, the prevalence of non-alcoholic fatty liver disease among children and 
adolescents is growing. Current data suggest that insulin resistance is one of the main factors in the pathogenesis of non-alcoholic 
fatty liver disease, and the content of fragments of caspase-cleaved cytokeratin-18 in the blood serum may be one of the informa-
tive indicators of non-alcoholic fatty liver disease progression.
The aim. To determine mechanisms of formation and progression of non-alcoholic fatty liver disease in obese children 
and adolescents by evaluating the level of cytokeratin-18.
Materials and methods. The study involved 46 adolescents with obesity and non-alcoholic fatty liver disease aged 12– 
17 years: 19 boys (41.3 %) and 27 girls (58.7 %). Clinical (weight, height, waist and hip circumference), laboratory (glucose, im-
munoreactive insulin, lipid metabolism, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, 
cytokeratin-18) parameters were studied and instrumental examination (abdominal ultrasound) was performed. To assess insulin 
resistance the triglyceride-glucose index was calculated.
Results. Depending on the presence of insulin resistance patients were divided into two groups: 21 (45.7 %) of adoles-
cents with insulin resistance and 25 (54.3 %) of adolescents without insulin resistance. Blood tests in patients with insulin re-
sistance revealed significantly higher levels of total cholesterol, triglycerides, very low-density lipoprotein cholesterol, fasting 
immunoreactive insulin, cytokeratin-18 and gamma-glutamyl transpeptidase. All adolescents were divided into 2 groups de-
pending on the level of cytokeratin-18: patients with cytokeratin-18 >233 mIU/ml and <233 mIU/ml (15 (32.6 %) and 31 (67.4 %) 
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respectively). It was found that there were significantly more patients with insulin resistance in the group with the level of 
cytokeratin-18 >233 mIU/ml.
Conclusion. In obese adolescents with non-alcoholic fatty liver disease insulin resistance is associated with more pro-
nounced disorders of lipid and carbohydrate metabolism and higher levels of markers that characterize the state of the liver such 
as cytokeratin-18 and gamma-glutamyl transpeptidase. Adolescents with obesity and non-alcoholic fatty liver disease with a 
threshold level of cytokeratin-18, which indicates the transformation of steatosis into steatohepatitis, two times more often have 
present insulin resistance. 
Keywords: obesity, non-alcoholic fatty liver disease, triglyceride-glucose index, cytokeratin-18, adolescents.
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1. Introduction
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dis-
ease in children and adolescents in the developed world. NAFLD is associated with a number 
of metabolic risk factors, including obesity, dyslipidemia, insulin resistance, and cardiovascular 
disease, and is considered a hepatic manifestation of metabolic syndrome [1, 2]. The prevalence of 
NAFLD among children and adolescents is growing in parallel with the global obesity epidemic. 
According to the significant research of recent years, 34.2 % of obese children and adolescents suf-
fer from NAFLD, which is 4.5 times more than in the general population [3]. Pathological changes 
in NAFLD are characterized by stages: vesicular steatosis of the liver can subsequently progress to 
non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, which is the foundation for the develop-
ment of hepatocellular carcinoma in adults [2]. The “gold standard” for assessing the condition of 
liver tissue is a biopsy. But due to the fact that the procedure is technically demanding and involves 
a risk of complications, a number of serum biomarkers are currently being studied to assess patho-
logical changes in the organ.
Cytokeratin-18 (CK-18) is a fragment of intermediate filaments of liver epithelial cells, 
and apoptosis of hepatocytes is considered one of the main mechanisms of NAFLD development. 
During apoptosis, activation of caspases occurs, which leads to proteolysis of cellular proteins 
including CK-18. This process can further cause the activation of stellate cells associated with 
fibrosis processes [4]. Therefore, the content of fragments of caspase-cleaved cytokeratin-18 in the 
serum, according to many researchers, may be one of the informative indicators of inflammation 
and fibrosis in NAFLD.
A key component of obesity and NAFLD is insulin resistance (IR), and although it is 
currently considered a debatable question about cause-and-effect relationships in this triad, the 
leading idea is that these are inextricably linked processes [5]. The most accurate tool for assess-
ing the action of insulin is the hyperinsulinemic-euglycemic clamp technique [6]. However, this 
method is expensive, time-consuming and thus not widely used in clinical practice. Instead, a 
number of indices have been developed to determine IR, including HOMA-IR, Caro, Matsuda, 
QUICKI, etc. [7, 8]. Based on the fact that insulin has a significant effect on lipid metabolism, a 
new tool for calculating IR has recently been proposed – the triglyceride-glucose index [9].
Current data indicate that IR is one of the main factors in the progression of NAFLD from 
simple steatosis in the NASH [10, 11]. Thus, today the issue of the influence of insulin resistance 
on the indicators characterizing the state of the liver in patients with NAFLD in children and ado-
lescents is relevant.
The aim. To determine mechanisms of formation and progression of non-alcoholic fatty 
liver disease in obese children and adolescents by evaluating the level of cytokeratin – 18.
2. Materials and methods 
The study involved 46 adolescents with obesity and NAFLD aged 12–17 years: 19 boys 
(41.3 %) and 27 girls (58.7 %) who were treated at the SI “Institute for Children and Adolescent 
Health Care at the National Academy of Medical Sciences of Ukraine” in 2018–2019. The diag-
nosis of obesity was established according to the ICD-10. NAFLD was diagnosed on the basis of 
an abdominal ultrasound examination. Other causes of liver disease were excluded in all patients.
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Anthropometric examination included measurement of standing height, body weight, waist 
circumference (WC), hip circumference (HC), calculation of the WC/HC ratio, the WC/height ratio 
(indicators of abdominal obesity), body mass index (BMI) using the formula: BMI=body weight (kg)/
height (m2). The BMI was assessed according to the standards of WHO. The study was conducted 
in accordance with the requirements of the Helsinki Declaration of the World Medical Association 
and approved by the local ethics committee of the “Kharkiv Medical Academy of Postgraduate Ed-
ucation” (protocol No. 1, 18.02.2020). All patients signed informed consent for participating in the 
clinical trial.
The venous blood samples were collected after 10–12 hours of night fasting. The concentra-
tions of serum glucose, immunoreactive insulin (IRI), alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), gamma-glutamyl transpeptidase (GGTP), total bilirubin, triglycerides (TG), 
total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) were measured. 
The concentrations of low-density lipoprotein cholesterol (LDL-C) and very low-density 
lipoprotein cholesterol (VLDL-C) were calculated using formula [12]: 
             LDL-C (mmol/l)=TC (mmol/l)–HDL-C (mmol/l)–TG (mmol/l)/2.2;  (1) 
                                     VLDL-C (mmol/l)=TG (mmol/l)/2.2.    (2) 
Insulin resistance was assessed by calculating the triglyceride-glucose (TyG) index: 
                 TyG index=Ln [ fasting TG (mg/dl)×fasting glucose mg/dl)]/2,  (3)
where 1 mmol/l of TG equals 88.57 mg/dl, 1 mmol/l of glucose equals 18 mg/dL. 
According to the method, the value of the index ≥4.75 for girls and ≥4.70 for boys indicates 
the presence of IR [9].
The level of cytokeratin-18 was determined by using an ELISA kit (CUSABIO, USA). Ul-
trasound examination was performed on an empty stomach using an «ULTIMA SM-50» with a 
3.5–5 MHz convex transducer and a 7.5–10 MHz linear transducer.
Statistical processing of material was performed using Microsoft Excel, Statistica 6.0. 
The data were expressed as mean ±SE. The distribution of the data was evaluated with the 
Kolmogorov-Smirnov test. Differences between groups were tested using Student’s t-test and 
chi-squared test (χ2). A p-value<0.05 was considered statistically significant.
3. Results
Depending on the presence of IR, patients were divided into two groups: 21 (45.7 %) of ad-
olescents with IR – I group (IR“+”) and 25 (54.3 %) of adolescents without IR – II group (IR“–”). 
The study revealed that 37 (80.4 %) of patients had increased appetite, 26 (56.5 %) – abdominal 
pain, 19 (41.3 %) – belching, 17 (36.9 %) – heartburn, 15 (32.6 %) – nausea, 14 (30.4 %) – flatu-
lence, 11 (23.9 %) – constipation, and 8 (17.4 %) had loose stools. Objective examination of patients 
revealed pain in the right hypochondrium in 21 (45.6 %) of adolescents, in the epigastrium in 
16 (34.7 %), liver enlargement was noted in 44 (95.6 %) patients. The frequency of complaints did 
not differ depending on the presence of IR. 
When determining anthropometric parameters significantly higher in patients with IR 
were BMI (32.91±0.4 kg/m2 vs 30.09±0.62 kg/m2, p≤0.01) and the WC/height ratio (0.58±0.01 vs 
0.55±0.03, p≤0.05). The characteristic of laboratory parameters of the examined adolescents is 
presented in Table 1. 
Among the laboratory parameters significantly higher in patients of group I were the levels 
of TC (p≤0.01), TG (p≤0.01), VLDL-C (p≤0.01), fasting IRI (p≤0.05), GGTP (p≤0.05), and the 
levels of glucose, LDL-C, HDL-C did not differ. Significantly higher level of CK-18 (p≤0.05) was 
observed in the group of adolescents with IR (Fig. 1). 
In the study of Feldstein A.E. et al. the level of cytokeratin-18 in children with biopsy prov-
en NAFLD was analyzed [13]. It was concluded that the value of 233 mIU/ml has the highest 
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sensitivity and specificity (85.0 % and 86.9 % respectively) for the establishment of NASH. Us-
ing these data, all adolescents in our study were divided into 2 groups depending on the level 
of cytokeratin-18: group I – 15 patients with cytokeratin-18 >233 mIU/ml (32.6 %), group II – 
31 patients with cytokeratin-18 <233 mIU/ml (67.4 %). It was found that there were significantly 
more patients with insulin resistance in group I than in the group of adolescents with the level of 
cytokeratin-18 <233 mIU/ml (10 (66.7 %) and 11 (35.5 %), respectively, p≤0.05).
Table 1
The characteristic of laboratory parameters of the examined adolescents depending on the presence of insulin 
resistance (mean±SE)
Parameters I group, IR“+” (n=21) II group, IR“–”(n=25)
Total bilirubin (µmol/l) 15.58±1.16 16.78±0.97
Total cholesterol (mmol/l) 5.58±0.21** 4.92±0.14
Triglycerides (mmol/l) 1.89±0.09** 1.07±0.04
LDL-C (mmol/l) 3.19±0.19 2.760.14±
VLDL-C (mmol/l) 0.84±0.04** 0.48±0.02
HDL-C (mmol/l) 1.54±0.07 1.67±0.08
Glucose (mmol/l) 4.91±0.11 4.78±0.07
IRI (μIU/ml) 29.3±2.81* 20.61±2.33
AST (U/L) 27.61±2.58 26.75±1.95
ALT (U/L) 28.01±2.97 27.87±2.25
GGTP (U/L) 23.85±1.31* 21.17±1.35
CK-18 (mlU/ml) 226.85±19.17* 181.71±11.43
Note: AST – aspartate aminotransferase; ALT – alanine aminotransferase; GGTP – gamma-glutamyl transpeptidase; VLDL-C – 
very low-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-density lipoprotein cholester-
ol; IRI – immunoreactive insulin; CK-18 – cytokeratin-18. Statistically significant difference: * – p≤0.05; ** – p≤0.01
Fig. 1. The level of cytokeratin-18 depending on the presence of insulin resistance in obese 
adolescents with NAFLD: IR “+” – the group of adolescents with insulin resistance,  









Currently, an active study of the relationship between IR and NAFLD is being conducted. 
The triglyceride-glucose index is proposed as a new alternative marker for determining IR. The re-
liability of the tool is confirmed by studies that have shown its compliance with the results obtained 
by the method of hyperinsulinemic euglycemic clamp and the calculation of other known indices 
for determining IR in both adults and pediatric population [14–16].
Schwimmer J. et al. were among the first who investigated the association of IR and 
NAFLD in obese children and adolescents. The study demonstrated significantly higher levels 
of the insulin resistance index (HOMA-IR) in children with NAFLD compared to the values of 
healthy peers [17]. Since then, the relationship between NAFLD and IR has also been described 
in other studies involving children and adolescents.
In present study, such anthropometric parameters as BMI and the WC/height ratio, which 
characterize abdominal obesity associated to NAFLD, were linked to higher levels of TyG. This 
is consistent with data from a study by Calcaterra V. et al, where a positive association of TyG 
index with BMI and the WC/height ratio in obese children was observed [18]. As in the work of 
Locateli J. C. et al. [19] present study demonstrated the deterioration of carbohydrate and lipid 
metabolism in the presence of IR, based on calculating TyG index in obese children and adoles-
cents with NAFLD.
The discovery of new biomarkers that characterize the state of the liver contributes to a bet-
ter understanding of the mechanisms underlying the relationship between IR, obesity and NAFLD. 
According to data of many researchers, the level of fragments of caspase-cleaved CK-18 in the 
blood serum may be one of the informative indicators of the progression of NAFLD [20, 21]. Thus, 
the determination of the level of CK-18 was proposed as a marker for predicting the presence of 
NASH in the study of Feldstein A. et al. [13] and fibrosis in the works of Fitzpatrick E. et al., Leb-
ensztejn D.M. et al. [22, 23] in children and adolescents with NAFLD. Interesting was the study of 
Vuppalanchi et al., which revealed a significant decrease in the level of CK-18 with an improvement 
in the dynamics of NAFLD in children after treatment [24].
It was noted in the report of the ESPGHAN Hepatology Committee that high GGTP levels 
are associated with fibrotic changes in the liver [25]. In the present study, higher levels of CK-18 
and GGTP were found in adolescents from the group with existing IR, which indicates the influ-
ence of IR on the progression of NAFLD.
The limitation of the study was the lack of additional verification of the diagnosis of 
NAFLD by ultrasound shear wave elastography.
Prospects for further research. The search and study of potential biomarkers that charac-
terize the condition of the liver will help improve the diagnosis and prognosis of NAFLD in obese 
children and adolescents.
5. Conclusions 
1. In adolescents with obesity and NAFLD, atherogenic changes in the lipid spectrum are 
detected, which are manifested by increased levels of total cholesterol, triglycerides and very 
low-density lipoproteins. These indicators are significantly higher in patients with present insulin 
resistance.
2. Adolescents with obesity and NAFLD have higher activity of gamma-glutamyl trans-
peptidase on the background of insulin resistance, which may indicate the progression of steatosis 
towards steatohepatitis.
3. Higher level of cytokeratin-18 is revealed in adolescents with obesity and NAFLD in the 
presence of insulin resistance.
4. Adolescents with obesity and NAFLD with a threshold level of cytokeratin-18, which 
indicates the transformation of steatosis into steatohepatitis, two times more often have present 
insulin resistance. 
Thus, the presented study confirms the possibility of fibrotic changes and progression of 
the inflammatory process in the liver in obese adolescents with NAFLD, which are more likely to 
occur on the background of insulin resistance.
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COMPARATIVE ASPECTS OF PLACENTAL DYSFUNCTION 
IN WOMEN USING DIFFERENT METHODS OF 
CONTRACEPTION IN ANAMNESIS
Oleksandra Lubkovska
Department of Obstetrics, Gynecology and Perinatology
Ukrainian State Institute of Reproductology
Shupyk National Medical Academy of Postgraduate Education
9 Dorohozhytska str., Kyiv, Ukraine, 04112
Abstract
The aim. To reduce the incidence of perinatal pathology in women who have used various methods of contraception, 
based on the study of the functional state of the fetoplacental complex (FPS), as well as improving diagnostic measures and tactics 
of pregnancy.
Materials and methods. 140 pregnant women were studied with their division into control and 3 test groups depending 
on the method of contraception in the anamnesis, using clinical, laboratory and instrumental research methods during pregnancy 
and childbirth.
Results. The study found that women with a history of intrauterine contraception (IUC), in contrast to combined oral 
contraception (COC) and combined oral contraception containing folate (COC+F), had a higher incidence of complications during 
pregnancy and childbirth, as well as fewer newborns with a satisfactory condition at birth. Assessment of folic acid levels at 6-8 
weeks of gestation showed significantly better results among women with a history of COC+F, compared with IUC and COC. In 
the group of women with IUC in the anamnesis, significantly worse mean endocrinological values prevailed, and there was also 
a greater number of pregnant women with disorders of fetal-placental blood flow. More pronounced dystrophic changes in the 
placentas of women in this group were pathomorphologically confirmed.
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